David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFII
1751
DELISTED
Electronics for Imaging
EFII
| $3.46M | ﹤0.01% |
128,557
+52,211
| +68% | +$1.37M |
|
|
ROIC
1752
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.44M | ﹤0.01% |
198,512
-236,321
| -54% | -$4.04M |
|
1753
Methanex
MEOH
$4.4B
| $3.44M | ﹤0.01% |
60,439
+6,945
| +13% | +$392K |
|
|
DSPG
1754
DELISTED
DSP Group Inc
DSPG
| $3.44M | ﹤0.01% |
244,215
+5,138
| +2% | +$66.8K |
|
1755
CALL
Devon Energy
DVN
$51.5B
| $3.43M | ﹤0.01% |
108,700
+71,500
| +192% | +$2M |
|
1756
Idacorp
IDA
$7.99B
| $3.42M | ﹤0.01% |
34,400
-36,086
| -51% | -$3.5M |
|
|
ALTR
1757
DELISTED
Altair Engineering Inc
ALTR
| $3.41M | ﹤0.01% |
92,673
-15,172
| -14% | -$510K |
|
1758
Matrix Service
MTRX
$302M
| $3.41M | ﹤0.01% |
174,085
-39,390
| -18% | -$805K |
|
1759
Capitol Federal Financial
CFFN
$1.07B
| $3.4M | ﹤0.01% |
254,909
-116,143
| -31% | -$1.54M |
|
|
GPMT
1760
Granite Point Mortgage Trust
GPMT
$50.6M
| $3.38M | ﹤0.01% |
181,967
+37,021
| +26% | +$699K |
|
|
CVET
1761
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.37M | ﹤0.01% |
+105,857
| New | +$3.76M |
|
|
EXAS
1762
PUT
DELISTED
Exact Sciences
EXAS
| $3.37M | ﹤0.01% |
38,900
-94,100
| -71% | -$8.01M |
|
|
STMP
1763
CALL
DELISTED
Stamps.com, Inc.
STMP
| $3.36M | ﹤0.01% |
41,300
-48,700
| -54% | -$6.85M |
|
1764
Banco Santander Chile
BSAC
$16.6B
| $3.35M | ﹤0.01% |
112,709
+24,764
| +28% | +$773K |
|
1765
Diodes
DIOD
$4.17B
| $3.34M | ﹤0.01% |
96,338
-59,614
| -38% | -$2.14M |
|
1766
Lesaka Technologies
LSAK
$390M
| $3.34M | ﹤0.01% |
929,608
+299,161
| +47% | +$1.23M |
|
|
RDS.A
1767
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $3.32M | ﹤0.01% |
53,050
-454,109
| -90% | -$28.1M |
|
1768
Prologis
PLD
$136B
| $3.32M | ﹤0.01% |
46,091
-24,132
| -34% | -$1.65M |
|
1769
Caleres
CAL
$440M
| $3.31M | ﹤0.01% |
134,178
+124,466
| +1,282% | +$3.56M |
|
1770
PUT
Kroger
KR
$35.8B
| $3.31M | ﹤0.01% |
134,600
-1,090,600
| -89% | -$29.9M |
|
1771
Emergent Biosolutions
EBS
$306M
| $3.31M | ﹤0.01% |
65,472
-35,103
| -35% | -$2.07M |
|
|
CRZO
1772
PUT
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $3.31M | ﹤0.01% |
265,000
+197,000
| +290% | +$2.34M |
|
|
ULTI
1773
CALL
DELISTED
Ultimate Software Group Inc
ULTI
| $3.3M | ﹤0.01% |
10,000
| – | – |
|
1774
Erie Indemnity
ERIE
$13.5B
| $3.3M | ﹤0.01% |
18,474
-1,763
| -9% | -$283K |
|
1775
McGrath RentCorp
MGRC
$2.79B
| $3.3M | ﹤0.01% |
58,304
+12,215
| +27% | +$653K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.